Current Issue
February 8, 2018: 131 (6)
Free Articles
Immediate free access granted by Editor-in-Chief
Plenary Paper
First Edition
Clinical Trials & Observations
Review Series
- Hematologic Disease at Older Age
- Therapeutic Antibodies
- Precision Hematology
- Clinical Platelet Disorders
- Transcription Factors in Hematopoiesis and Hematologic Disease
- Leukemic Stem Cells
- T-Cell Malignancies
- Myeloproliferative Neoplasms
- Chronic GVHD: from Pathogenic B-cell Receptor Signaling to Novel Therapeutic Targets
- Advances in Cell-Based Immune Therapeutics in Hematology
- Genome Editing in Hematology
- Updated WHO Classification of Hematological Malignancies
- The Paradox of Indolent B-cell Lymphoma
- Megakaryocytes to Platelets in Health and Disease
February 8, 2018: 131 (6)
Multimedia
-
Review Series: Hematologic Disease at Older Age
Gerald de Haan, PhD and Gregory A. Abel, MD, MPH discuss highlights of this review series which highlights common biologic and clinical concepts related to hematologic disease associated with aging.
-
Review Series: Therapeutic Antibodies
Ken H. Young, MD, PhD shares some highlights of this review series which describes the emerging mechanistic insights and therapeutic value of different classes of antibody therapy, including direct antibodies; “accelerator” antibodies against coreceptors; and antibodies reversing regulatory T-cell activity, for a variety of hematological malignancies.
-
Review Series: Precision Hematology
Edited with an introduction by Dr Benjamin L. Ebert, we present a series of reviews focused on precision hematology. This series presents the state of the art usage of genomic techniques for the identification of inherited and acquired mutations guiding the diagnosis and treatment of hematologic disorders, the methods for gathering and storing genomic data, and the ethical considerations in such genomic testing.